Harshadha B.1*, Revathi S.2, Dinesh C.3, Gokul S.4, Sinega C.5

ARTIFICIAL INTELLIGENCE IN DRUG REPURPOSING FOR PARKINSON'S DISEASES: A COMPREHENSIVE REVIEW

Parkinson’s disease (PD), the second most common neurodegenerative disorder, remains a major challenge in drug discovery due to its complex pathophysiology involving α-synuclein aggregation, oxidative stress, mitochondrial dysfunction, and neuroinflammation. Conventional drug dev...